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A B S T R A C T
Corneal transplantation constitutes one of the leading treatments for severe cases of loss of corneal function. Due
to its limitations, a concerted effort has been made by tissue engineers to produce functional, synthetic corneal
prostheses as an alternative recourse. However, successful translation of these therapies into the clinic has not
yet been accomplished. 3D bioprinting is an emerging technology that can be harnessed for the fabrication of
biological tissue for clinical applications. We applied this to the area of corneal tissue engineering in order to
fabricate corneal structures that resembled the structure of the native human corneal stroma using an existing 3D
digital human corneal model and a suitable support structure. These were 3D bioprinted from an in-house
collagen-based bio-ink containing encapsulated corneal keratocytes. Keratocytes exhibited high cell viability
both at day 1 post-printing (> 90%) and at day 7 (83%). We established 3D bio-printing to be a feasible method
by which artificial corneal structures can be engineered.
1. Introduction
The World Health Organisation estimates that 10 million people
worldwide require surgery to prevent corneal blindness as a result of
trachoma, with a further 4.9 million suffering from total blindness due
to corneal scarring (Whitcher et al., 2001). Even with adequate num-
bers of prospective cornea donors, a considerable discrepancy exists
between the supply and demand of transplantable corneas (Golchet
et al., 2000). The unmet clinical need for cornea donors has led to in-
creasing effort in the development of artificial corneal substitutes,
which must meet specific criteria if they are to functionally mimic the
native cornea.
The cornea serves as the protective, outermost layer of the eye and
is responsible for the transmission and refraction of incident light
beams that are in turn focused onto the retina by the lens (Eghrari et al.,
2015; Meek and Knupp, 2015; Griffiths et al., 2016). Its near-perfect
spherical anterior surface, together with the index of refraction change
at the air/tear film interface, account for approximately 80% of the
total refractive power of the human eye (Ruberti and Zieske, 2008). The
ability to recapitulate the rotational symmetric curvature necessary for
optical refractive power is therefore fundamental to the design frame-
work that exists for engineering functional corneal substitutes (Muller
et al., 2001; Ruberti and Zieske, 2008).
It is the distinct arrangement of collagen lamellae in the corneal
stroma that is responsible for maintaining the strength and shape of the
cornea (Farrell and McCally, 2000). The corneal stroma comprises
somewhere between 200 and 250 lamellae that are assembled
heterogeneously throughout its depth, with the lamellae in the mid to
posterior stroma lying in parallel while those in the anterior stroma are
interwoven with one other (Hogan et al., 1971). The complexity of
corneal microstructure presents an ongoing challenge when using tra-
ditional tissue engineering methods that focus on assembling corneal
extracellular matrix (ECM) in vitro. As such, the replication of human
corneal geometry remains to be fully realised within the context of
tissue engineering.
The ability to construct biosynthetic corneal models would be useful
for a number of applications, and this has been achieved in recent years
where, for example, corneal models have been required for the char-
acterisation of corneal cellular regeneration (Li et al., 2003) as well as
for modelling corneal fibrosis (Karamichos et al., 2014). In these in-
stances, corneal models were assembled using different techniques; the
study by Li et al. made use of plastic contact lens molds into which
hybrid collagen hydrogels were injected and crosslinked, while Kar-
amichos et al. plated human corneal fibroblasts (HCFs) onto six-well
plates bearing porous polycarbonate membrane inserts that were left in
culture over a period of weeks. The former method enabled the fabri-
cation of a curved corneal surface onto which corneal epithelial cells
could be seeded, cultured and eventually implanted, while the latter
relied upon cell proliferation and ECM secretion to render an in vitro 3D
model that could be used to study fibrosis reversal in the cornea.
3D bioprinting is a technique that has garnered notable interest for
tissue engineering applications for its ability to direct the hierarchical
assembly of 3-dimensional biological structures for tissue construction
(Mironov et al., 2006). Since its advent, 3D bioprinting has made
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possible the layer-by-layer deposition of biological materials in a pre-
scribed pattern corresponding with the anatomy of an organotypic
model (Zhang and Zhang, 2015). This model is usually acquired from
clinical images such as CT and MRI scans and is used as a means by
which to generate the fundamental printing paths on which 3D bio-
printing depends; these are expressed in the form of a unique G-code
that can be computed automatically by 3D printing software at re-
solutions specified by the chosen print parameters (Murphy and Atala,
2014). The ability to replicate features such as concavity, undercuts and
convoluted patterns is therefore a function of the complexity of two-
dimensional figures, such as points, lines and circles (Chia and Wu,
2015). The final, post-printing stage involves the cell-mediated re-
modelling of the printed biological construct in the presence of ap-
propriate physiological cues to ensure that it develops suitable bio-
mechanical, structural and functional properties (Jakab et al., 2010;
Mironov et al., 2011).
In this study, we examined the feasibility of generating complex 3D
bioprinted corneal stroma equivalents using pneumatic 3D extrusion
bioprinting. Printed constructs were anatomically analogous to a
human corneal model derived from the topographic data of an adult
human cornea, acquired in situ post-refractive surgery. Several low
viscosity bio-ink combinations were tested for their printability prior to
cell incorporation. Printing accuracy was evaluated by quantifying
central and peripheral thickness of the corneal construct and the via-
bility of encapsulated corneal keratocytes was evaluated on days 1 and
7 post-printing. Overall, our study provides a basis for further research
into the use of 3D bioprinting for the generation of artificial, biological
corneal structures for regenerative medicine applications.
2. Materials and methods
2.1. Digital model and support structure generation
A patient-specific digital corneal model constructed using a rotating
Scheimpflug camera with a Placido disk and discretised by the Finite
Element Method (FEM) was used (Simonini and Pandolfi, 2015). The
vertical and horizontal diameters of the model measured
12.377mm×12.385mm, respectively, while its thickness measured
approximately 500 μmat the centre and 823 μm towards the periphery.
The corneal model was used as a template with which to build a digital
support structure on AutoCAD 2017 (version 20.1) in order to facilitate
the 3D bioprinting process. This was made possible by sealing the rim of
the model cornea with a planar circle (r= 6.5mm) such that it then
resembled a dome; the modified model was then subtracted from the
centre of one of the square faces of a digital cuboid
(23.7 mm×23.7 mm x 6mm) that was designed to sit neatly inside a
35mm Petri dish. The resulting support structure was exported as an
STL file and 3D-printed at a resolution of 100 μm with white Acrylo-
nitrile Butadiene Styrene (ABS) using a CEL Robox 3D printer.
2.2. G-code export and printing setup
The 3D printing software Slic3r (1.2.9) was configured with an
INKREDIBLE bioprinter (Cellink AB, Gothenburg, Sweden). A stereo-
lithography (STL) file of the corneal model was imported onto Slic3r,
from which versions of G-code were subsequently exported. Printing
speed was set at 6mms−1 and 30G high precision blunt needles
(CELLINK, AB) were used in all experiments.
2.3. Bio-ink preparation
Sodium alginate (Acros Organics brand, ThermoFisher Scientific,
U.K.) and methacrylated type I collagen (PhotoCol®, Advanced
Biomatrix, USA) were used to prepare all bio-inks. Methacrylated col-
lagen was first dissolved in acetic acid and subsequently neutralized
with sodium hydroxide at 4 °C, following the supplied preparation
protocol. Six bio-inks were formulated in total, two of which comprised
3% (w/v) sodium alginate and 8mg/ml methacrylated collagen only.
The final four bio-inks, termed Coll-1 to Coll-4, had various combina-
tions of methacrylated collagen mixed with 2% (w/v) sodium alginate
to the following ratios: (i) Coll-1: one part 8mg/ml collagen to two
parts alginate; (ii) Coll-2: one part 8mg/ml collagen to three parts al-
ginate, (iii) Coll-3: one part 6mg/ml collagen to two parts alginate; and
(iv) Coll-4: one part 6mg/ml collagen to three parts alginate.
2.4. Cell culture
Corneal keratocytes are the most abundant cell type in the corneal
stroma, itself comprising 80% of corneal thickness, and were therefore
deemed a suitable cell type for bio-ink formulation. Human corneal
stromal cells were isolated, as previously described (Gouveia and
Connon, 2013), from cadaverous human corneal tissue (male/female,
age 60–80 years and with no prior history of corneal diseases or ocular
trauma, research consent given) obtained from NHS Blood and Trans-
plant (NHSBT) through a service level agreement with Newcastle-upon-
Tyne Hospitals NHS Foundation Trust, U.K.. Briefly, the epithelia-de-
pleted corneal tissues were finely chopped using a scalpel, transferred
to DMEM/F12 medium (ThermoFisher Scientific) supplemented with
5% fetal bovine serum (FBS; BioSera, Labtech International, U.K.), 2 g/
L (450 units/mL) collagenase type-1 (ThermoFisher Scientific) and in-
cubated at 37 °C under continuous rotation for 5 h, followed by in-
cubation with 0.25% trypsin-EDTA (ThermoFisher Scientific) for
10min. The isolated corneal stromal cells were plated onto tissue cul-
ture flasks (Greiner Bio-One, U.K.) and maintained using DMEM/F12
medium supplemented with 5% FBS and 1% penicillin/streptomycin
(ThermoFisher Scientific). Media were changed every 2–3 days, and
cultures were maintained until reaching 70–80% confluence. At this
point fibroblasts underwent serum starvation for a period of 3 days to
promote their differentiation into keratocytes. During this time, cells
were cultured in serum-free medium comprised of DMEM/F12 with
1×10−3 M ascorbic acid (Sigma-Aldrich, U.K), 1× ITS (Sigma-Al-
drich), and 1% penicillin/streptomycin. Cells were used at passage 3.
2.5. 3D bioprinting and optimisation
A pneumatic, dual extruder 3D bioprinter was used to print corneal
stromal equivalents. This was calibrated so that bioprinting began from
the centre of the support and then outwards and upwards towards the
rim. Following calibration, the hollowed-out section of the bespoke 3D
printed plastic support was filled with gelatine slurry in order to fa-
cilitate the printing of low viscosity collagen and alginate bio-inks while
maintaining printability; the gelatine slurry was prepared using the
Freeform Reversible Embedding of Suspended Hydrogels (FRESH)
starter kit and protocol provided by Allevi (USA). The support was then
returned to the printing plate for the duration of the printing process.
Corneal structures were extruded at air pressures of 180 KPa, 15 KPa,
40 KPa, 20 KPa, 15 KPa and 10 KPa for bio-inks comprising 3% alginate
alone, 8 mg/ml methacrylated collagen alone, Coll-1, Coll-2, Coll-3 and
Coll-4, respectively. A phosphate buffered saline (ThermoFisher Sci-
entific) (PBS)-based slurry and a calcium chloride (Sigma-Aldrich)
(CaCl2)-based slurry were prepared for use with collagen and alginate
bio-inks respectively, with the latter additionally used for the printing
of composite bio-inks. Corneal structures printed using alginate-based
bio-inks were crosslinked with 100 μl of 1% (w/v) CaCl2 and were
immediately incubated at 37 °C for 8min, while structures printed from
collagen alone were incubated for 30min at 37 °C. The gelatine slurry
was aspirated after incubation leaving behind printed and stabilised
constructs that were then detached from the support and stored in PBS
thereafter. Corneal structures printed with composite bio-inks were
crosslinked in 100 μl CaCl2 and incubated at 37 °C for 8min; the CaCl2
was then aspirated and replaced with an equal volume of PBS and in-
cubated for a further 20min at 37 °C. Serum-free medium was used in
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place of PBS once cells were incorporated into the bio-ink. After
printability had been optimized, corneal keratocytes were incorporated
into Coll-1 at a concentration of 2 million cells/ml. These were printed
using a nozzle diameter of 200 μm and were maintained in serum-free
medium for 7 days subsequent to printing.
2.6. OCT sectioning
Prior to cell incorporation, composite corneal structures were
printed with Coll-1 at nozzle diameters of 200 μm and 300 μm, em-
bedded in optical cutting temperature gel and frozen for 1 h. Cross-
sectional slices taken through the centre were imaged using a Leica DM
IL LED microscope (Leica, UK) and the thickness at both the centre and
the periphery were measured using ImageJ (1.48v) software (Schneider
et al., 2012).
2.7. Cell viability evaluation
Viable cell number and percentage viability of corneal keratocytes
were assessed using a Countess II FL automated cell counter (Invitrogen
brand, ThermoFisher Scientific). Corneal structures were stained with
1 μM Calcein-AM (eBioscience brand, ThermoFisher Scientific) and
2 μM Ethidium Homodimer 1 (Sigma-Aldrich) at 37 °C for 15min.
Fluorescent images were captured on days 1 and 7 post-printing using a
Leica DM IL LED microscope (Leica, UK) from which cell viability was
calculated using ImageJ (1.48v) software (Schneider et al., 2012).
Briefly, RGB images of separate channels were first converted to binary
images to enable the counting of cells by analysing particle number.
The range of particles to be counted was chosen based on area mea-
surements of the smallest and largest observed particles on each binary
image. Percentage viability was calculated as the number of live cells,
divided by the total number of cells (live and dead), multiplied by 100.
3. Results
3.1. Support structure generation
The geometry of a digital corneal model was required for the gen-
eration of 3D printed corneal structures. This was obtained previously
by the acquisition of cornea elevation maps and a point cloud defining
the anterior corneal surface, followed by the evaluation of missing
points by interpolation and the subsequent reconstruction and dis-
cretization of the cornea into finite elements (Simonini and Pandolfi,
2015). A support structure was additionally required in order to pre-
serve the shape of printed corneal constructs during and after bio-
printing. This was obtained by constructing a digital image that ex-
hibited a geometry complementary to that of the anterior corneal
surface. The SURFSCULPT command on AutoCAD was used to trans-
form the original cornea model together with a planar circle into a solid
dome structure (Fig. 1). The modified cornea was then positioned just
above the surface of a cuboid at its widest diameter to enable printing;
this was followed by the subtraction of its entire volume, generating a
structure that could support the printing of corneal constructs (Fig. 1).
The support structure was designed to closely fit inside a 35mm petri
dish to facilitate the transfer of the constructs for immediate incubation
(Fig. 1). Importantly, there was no interference between the needle and
the support structure during printing.
3.2. 3D bioprinting optimisation and evaluation of cornea-like structures
In order to print corneal structures, the original model cornea was
imported onto Slic3r so that versions of corresponding G-code could be
exported. Print directionality was set to concentric as this resulted in
the least disruption of deposited bio-ink. Similarly, a straight profile
needle was used in order to prevent possible disruption of the gelatine
slurry and over-dispensation of bio-ink (Fig. 2). Structures printed from
3% (w/v) sodium alginate bio-ink were sufficiently stiff such that cor-
neal curvature was maintained after detachment from the support.
Corneal constructs printed in the absence of the gelatine slurry pre-
scribed by the FRESH method either did not maintain their printed
shape, or, as was the case when a more viscous bio-ink was used,
clumped together as a result of the concentric movements of the needle.
Importantly, no needle blockage occurred and the gelatine slurry was
displaced to accommodate the bio-ink while simultaneously supporting
the formation of the corneal structure layer by layer. Following cross-
linking by addition of CaCl2, the resulting corneal structures detached
from the plastic support without difficulty and retained their shape
after transferal into PBS. However, when corneal keratocytes cells were
incorporated into the alginate bio-ink the resulting printed corneal
structures began to unravel with minimal mechanical stimulation
(Fig. 2). To rectify this we first tried a collagen bio-ink in place of al-
ginate, but found that concentrations suited to our extrusion system
were not viscous enough i.e. unable to hold their shape once extruded
or the printed threads would diffuse through gelatine. We therefore set
about formulating a set of novel composite bio-inks comprising both
collagen and alginate in order to combine their respective material and
mechanical properties and, in doing so, optimise the print fidelity and
mechanical integrity of corneal structures.
3.3. Formulation and evaluation of composite bio-inks to print corneal
structures
Four composite bio-inks were formulated that incorporated combi-
nations of type I collagen and sodium alginate in varying proportions.
Structures printed with Coll-4 presented little structural integrity and
fragmented easily whereas those printed with Coll-3 remained intact
but were unable to maintain an appropriate degree of curvature
(Fig. 2). Thus, the concentration of incorporated collagen was then
raised to improve printability and strength. Structures printed with
Coll-2 displayed more curvature than those printed with Coll-3, while
the best preservation of corneal shape was obtained with the Coll-1 bio-
ink (Fig. 2). The enhanced stability of the corneal structures printed
with Coll-1 was attributed to the combined tensile strength of collagen
and alginate hydrogel stiffness post-crosslinking. Composite Coll-1
corneal structures also demonstrated an improved degree of transpar-
ency (compared to the collagen only bio-inks), which was aided by the
transparency of incorporated alginate (Fig. 2). Owing to its printability,
Coll-1 bio-ink was subsequently used to assess the effect of nozzle
diameter on print accuracy.
Due to the shortened printing path that is generated when nozzle
diameter is increased, central and peripheral corneal thickness was
significantly reduced when a nozzle diameter of 300 μm was applied
relative to the 200 μm nozzle due to the decrease in bio-ink deposition
(Fig. 2). The central and peripheral thickness of the 3D bioprinted
constructs were recorded as 609.4 μm and 711.2 μm for the 200 μm
nozzle, and 518.5 μm and 584.7 μm for the 300 μm nozzle, respectively.
Further experiments were conducted with a 200 μm nozzle setting as
these structures exhibited greater stability due to the additional points
of integration between adjacent layers of filament. Subsequent to cell
incorporation, high initial viability of corneal keratocytes was observed
on day 1 post-printing (92%) with discernible cell spreading and no cell
aggregates (Fig. 2). Cell viability remained high after 7 days at 83%.
4. Discussion
3D bioprinting is an additive manufacturing technology whereby
cells are combined with a suitable biomaterial and deposited within
micrometer precision, layer-by-layer, in order to generate tissue con-
structs for a variety of applications, including but not limited to tissue
engineering (Mandrycky et al., 2016). Much of its appeal lies in its high-
throughput ability, enabling the rapid fabrication of tissue scaffolds
with high definition. Pneumatic extrusion bioprinting in particular
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enjoys a simple driving mechanism whereby its operating force is de-
termined solely by the air-pressure capabilities of the system, where it
has been shown to accommodate material viscosities as low as 30mPa/
s (Murphy and Atala, 2014).
Corneal 3D bioprinting necessitates the use of low viscosity bio-
materials for the physical extrusion of bio-ink at high resolutions. The
incorporation of a method that facilitates the 3D bioprinting of low
viscosity bio-inks by preserving their intricate form during bio-ink
dispensation was therefore fundamental. In this study, we demon-
strated that keratocyte-laden corneal stromal equivalents can be 3D
bioprinted using specially developed low viscosity bio-inks at high re-
solutions using the FRESH method.
We established that the presence of both a gelatine slurry and a
support structure was ideal for the fabrication of anatomically robust
corneal structures. The use of a gelatine slurry for 3D bioprinting ap-
plications was first described by Hinton et al. who noted that the ge-
latine microparticles behave as a rigid body at low shear stresses yet
flow as a viscous fluid at high shear stresses, thus accommodating the
continuous extrusion of bio-ink while retaining the shape of previously
deposited bio-ink (Hinton et al., 2015). In this study, we observed the
gelatine slurry gradually migrate towards the centre of the support
structure to make way for the construct being printed. We also noted
that, in the absence of a suitable support structure, corneal structures
did not retain their curvature after aspiration of the slurry and that this
likely occurred due to the rapid dissolution of the small volumes re-
quired to hold the printed constructs in place during printing. A be-
spoke support structure with the inverse shape to the cornea model was
therefore constructed and used in conjunction with and after bio-
printing. Consequently, the gelatine solution could be aspirated and
replaced with growth medium and/or cross-linked while the constructs
were still being supported.
Collagen constitutes a major component of corneal ECM (Ruberti
and Zieske, 2008; Cen et al., 2008) and therefore presents a natural
choice for generating bioengineered corneal structures. Low con-
centrations of collagen do not however possess the necessary stiffness to
enable the fabrication of robust corneal structures via an extruding 3D
bioprinter, where precise control over microarchitecture presents a
major challenge. Hydrogels have been extensively used for tissue en-
gineering applications for their structural resemblance to the ECM, their
low toxicity and tuneable biophysical properties (Lee and Mooney,
2012; Drury et al., 2004; Klöck et al., 1997), including use in the cornea
(Wright et al., 2012; Rafat et al., 2008; Guo et al., 2013). We undertook
to compose a range of composite bio-inks comprising both collagen and
alginate in an effort to combine the tensile strength of collagen with the
biomechanical properties of alginate for the formation of printable
corneal structures. Constructs printed with bio-ink Coll-1 in particular
exhibited enhanced mechanical stability, which increased with the
proportion of incorporated alginate.
The peripheral and central measurements acquired from tissue
sectioning revealed the effect nozzle diameter had on print accuracy.
Reduction in nozzle diameter resulted in a lengthening of the 3D
printing path, giving rise to additional points of fusion between de-
posited filaments and an increase in mechanical stability. With all other
print parameters remaining constant, a greater volume of bio-ink is
invariably dispensed. Corneal constructs printed with a nozzle diameter
of 200 μm appeared more robust, but better print fidelity was observed
from those printed with a nozzle diameter of 300 μm. Thus, careful
adjustment of print parameters such as printing speed, needle diameter
and bio-ink viscosity can ensure both mechanical stability and print
accuracy are achieved.
The all-encompassing challenge in 3D bioprinting concerns the
ability to print intricate structures in which cells are able to retain
viability without printability being compromised. Interpenetrating
networks of alginate and collagen have previously been shown to
provide a favourable environment suited to cell growth, where cells
have manifested varying morphologies depending on material stiffness
(Branco da Cunha et al., 2014). In this study, high initial viability of
encapsulated corneal keratocytes in composite collagen and alginate
bio-inks and noticeable spreading were observed. One of the limitations
of extrusion 3D bioprinting is the generation of shear stress-induced cell
deformation at the needle wall and which is diminished by the use of
low viscosity bio-inks to which low air pressures can be applied
(Ozbolat and Yu, 2013). The prevention of dehydration due to the
presence of the gelatine slurry during printing and the thinness of the
printed tissue also likely contributed to initial cell viability. The con-
servation of high cell viability of encapsulated cells 7 days after bio-
printing points to the potential of composite collagen and alginate bio-
inks for 3D bioprinting applications.
Fig. 1. Stages of support structure generation. (A) Human cornea showing size and natural curvature across surface. (B) Original corneal model derived by (Simonini
and Pandolfi, 2015) via the Finite Element Method (FEM). Corneal model is first converted to a solid to enable the execution of Boolean operations required for the
generation of a support structure. Cornea is then ‘sealed’ (C) with a planar circle in order to subtract its volume from the support structure. (D) Wireframe view of
cornea situated at the centre of cuboid prior to subtraction. (E) Digital support structure after subtraction. (F) The 3D printed plastic support structure.
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The future success of corneal 3D bioprinting will ultimately depend
on the ability of encapsulated cells to mediate ECM remodelling in
order to establish tissue functionality. A distinctive feature of corneal
fibroblasts presents itself when they are seeded at the base of a curved
surface where they have recently been shown to migrate in lattice
formation and align collagen in a way that closely resembles its ar-
rangement in the cornea (Gouveia et al., 2017). A significant advantage
proffered by the present work is therefore the ability to reproduce
curved corneal geometry which is now known to directly influence cell
migration and collagen alignment. Thus, cells seeded at the base of a
Fig. 2. Using support structure to facilitate the printing of a corneal structure with 3% alginate (nozzle diameter= 200 μm) and optimisation of bio-inks for corneal
3D bioprinting. (A) Digital cornea is imported to the computer driving the 3D printer software slic3r and a preview of the concentric directionality of print is
displayed. (B) The support structure is coated with FRESH to facilitate the 3D bioprinting of corneal structures. (C) View of the 3D bioprinting process. Corneal
structures were printed with 3% alginate bio-ink stained with trypan blue to increase visibility. (D) Image of 3D bioprinted corneal structure captured prior to
incubation. (E) FRESH is aspirated after 8 min of incubation and corneal structure is carefully removed from support, but begins to unravel 1 day post-printing once
keratocytes were combined with the alginate bio-ink. (F) Images of corneal structures 3D bioprinted from composite bio-inks. (G) Relationship between nozzle
diameter and printed thickness of corneal structures (left) and depiction of transparency of corneal structure 3D bioprinted from Coll-1 bio-ink (H) Brightfield image
of 3D bioprinted corneal structure containing cells at day 1 (left) and cell viability measurements over 7 days (right). (I) Representative live/dead stain images using
fluorescence microscopy at days 1 and 7 after 3D bioprinting in Coll-1.
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scaffold bearing a close resemblance to corneal anatomy would po-
tentially be capable of remodelling the ECM in a way that is presently
unachievable with non-curved geometries.
Successful translation of this current proof-of-concept study will
first require further analysis of stromal cell phenotype, the bio-
compatibility of the construct following transplantation, its capacity to
support epithelial cell growth and, critically, its ability to impart a
functional corneal replacement. A significant benefit of this approach to
corneal tissue engineering is that both structural and biochemical
components of the equivalent can be rationally designed, allowing, in
theory, the printing of anatomical features such as the limbal zone and
Bowman's layer replete with appropriate soluble and insoluble factors.
5. Conclusion
In conclusion, our study provides a proof-of-concept for the use of
3D bioprinting as a rapid and effective method by which to fabricate
human corneal substitutes from low viscosity bio-inks. Successful rea-
lisation of this method presently relies upon a sustained effort towards
facilitating long-term matrix remodelling in order to validate clinical
suitability. In all, these findings demonstrate great promise for the
application of 3D bioprinting for corneal tissue engineering applica-
tions.
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